English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 4 July 2011, 01:00 HKT/SGT
Share:
    

Source: RIKEN
RIKEN: Genetic Variant Linked to Development of Liver Cancer in Hepatitis C Virus Carriers

TOKYO, July 4, 2011 - (ACN Newswire) - A genome-wide study by researchers at the RIKEN Center for Genomic Medicine, Hiroshima University Hospital and Sapporo-Kosei General Hospital has identified a genetic variant associated with the development of liver cancer in chronic hepatitis C virus carriers. The findings are based on a study of 3,312 Japanese individuals and appear in the journal Nature Genetics.

Hepatocellular carcinoma (HCC), the most common type of liver cancer, is the third leading cancer-related cause of death and the seventh most common form of cancer worldwide. The hepatitis C virus (HVC) is the main risk factor for HCC in many western countries and in Japan, where of the more than 30,000 deaths each year from HCC, 70% involve HVC.

To identify risk factors connecting HVC and HCC, the research group conducted a genome-wide study on a group of 3,312 Japanese individuals carrying the hepatitis C virus. Analyzing a total of 467,538 genetic markers (called single nucleotide polymorphisms or SNPs) in a group of 212 HCV carriers with HCC and 765 HCV carriers without HCC, the group uncovered one SNP associated with HCC risk, located on a gene called DEPDC5. The association was confirmed in an independent replication study on a population of 2335 HVC carriers, 710 with HCC and 1625 without HCC.

The significance of the findings was further highlighted when the researchers adjusted their results for gender, age and platelet count, revealing that among Japanese individuals with chronic HVC infection, the DEPDC5 SNP roughly doubles the odds of developing HCC.

While deepening our understanding of the mechanisms triggering HCC, the discovery of the DEPDC5 SNP locus also provides a valuable target for new therapy techniques, promising progress in the ongoing battle to overcome one of the world's most deadly cancers.

Contact:
Kazuaki Chayama
Laboratory for Digestive Diseases
RIKEN Center for Genomic Medicine (CGM),
Tel: +81-82-257-5955
Fax: +81-82-257-1559

Ms. Tomoko Ikawa (PI officer) 
Global Relations Office
RIKEN
Tel: +81-48-462-1225
Fax: +81-48-463-3687
Email: koho@riken.jp


Topic: Research and development
Source: RIKEN

Sectors: Science & Research, BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

RIKEN Related News
Tuesday, 10 October 2023, 16:29 JST
Fujitsu and RIKEN develop AI drug discovery technology utilizing generative AI to predict structural changes in proteins
Dec 17, 2013 15:20 HKT/SGT
A Novel Insight into Cardiac Function: Development of a New Model of Spontaneous Oscillatory Contraction
Feb 27, 2012 19:30 HKT/SGT
The Asian Research Network: a Collaboration to Boost Science
Sept 22, 2011 20:31 HKT/SGT
RIKEN: New Metal Hydride Clusters Provide Insights into Hydrogen Storage
Sept 22, 2011 19:03 HKT/SGT
Preserving Goat Semen and Other News from the Journal of Tropical Agricultural Science (JTAS)
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575